J. Piotrowski et al., SULGLYCOTIDE EFFECT ON THE PROTEOLYTIC AND LIPOLYTIC-ACTIVITIES OF HELICOBACTER-PYLORI TOWARD GASTRIC MUCUS, The American journal of gastroenterology, 89(2), 1994, pp. 232-236
Objectives: Infection with Helicobacter pylori is now recognized as a
major factor in the etiology of gastric disease, and among the detrime
ntal effects this bacterium exerts on the mucosal integrity is the ela
boration of extracellular protease and lipase enzymes capable of mucus
protein and lipids degradation. We present here evidence that the act
ivities of these enzymes are inhibited by an gastroprotective agent, s
ulglycotide. Methods: The grown colonies of bacterium were washed with
saline, filtered through sterilization filter, and the filtrate used
as the enzyme source. Results: In the absence of sulglycotide, the H.
pylori protease caused extensive degradation of human gastric mucus, w
hile free fatty acids, glycerol monooleate and lysophosphatidylcholine
were produced by the action of H. pylori lipase and phospholipase A e
nzymes. Introduction of sulglycotide to the incubation systems led to
the reduction in the rate of mucus protein and lipid degradation. The
rate of proteolysis inhibition was proportional to sulglycotide concen
tration up to 45 mu g/ml at which point a 43% reduction in mucus degra
dation was attained, whereas the maximum inhibition of lipase (39%) an
d phospholipase A (98%) activities occurred at a sulglycotide concentr
ation of 100 mu g/mI. Conclusions: This study indicates that sulglycot
ide is capable of counteracting the mucolytic activity of H. pylori, a
nd thus may be of value in the therapy of H. pylori-associated gastric
diseases.